CPI-613
CPI-613 is an E1α pyruvate dehydrogenase (PDH) modulator that prevents cancer cells from metabolizing glucose for energy. CPI-613 has been granted orphan drug status by the US FDA for pancreatic cancer.
| Trivial name | 6,8-Bis(benzylthio)octanoic acid |
| Catalog Number | CSN15809 |
| Alternative Name(s) | 6,8-Bis(benzylthio)octanoic acid |
| Research Area | Cancer |
| Molecular Formula | C22H28O2S2 |
| CAS# | 95809-78-2 |
| Purity | ≥98% |
| SMILES | O=C(O)CCCCC(SCC1=CC=CC=C1)CCSCC2=CC=CC=C2 |
| Size | 5mg |
| Supplier Page | https://www.csnpharm.com/products/cpi-613.html |